Institutional Ownership
Skye Bioscience Inc
CUSIP 83086J200COM NEWSKYEQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
37.3%
Max % of class reported
Institutional Holders
36
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Dec 16, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 16, 2025 | 5am Partners Vii, LLC | 13D/A | 34.0% | — | SEC |
| 2 | Aug 14, 2025 | Schonfeld Strategic Advisors LLC | 13G/A | 3.6% | 1.12M | SEC |
| 3 | May 15, 2025 | Schonfeld Strategic Advisors LLC | 13G | 5.2% | 1.62M | SEC |
| 4 | Apr 10, 2025 | Sphera Funds Management Ltd. | 13G/A | 4.8% | 1.48M | SEC |
| 5 | Dec 19, 2024 | 5am Partners Vii, LLC | 13D/A | 36.4% | — | SEC |
| 6 | Nov 14, 2024 | Altium Capital Management LP | 13G/A | 4.3% | 1.32M | SEC |
| 7 | Nov 14, 2024 | Janus Henderson Group PLC | 13G/A | — | — | SEC |
| 8 | Aug 14, 2024 | Janus Henderson Group PLC | 13G | 5.7% | 1.73M | SEC |
| 9 | Mar 13, 2024 | 5am Partners Vii, LLC | 13D/A | 33.9% | 10.10M | SEC |
| 10 | Feb 8, 2024 | Sphera Funds Management Ltd. | 13G | 5.4% | 1.30M | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Skye Bioscience Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | 5am Venture Management, LLC | 9.68M | $5.95M |
| 2 | Versant Venture Management, LLC | 2.01M | $1.23M |
| 3 | Baker Bros. Advisors LP | 1.58M | $968.1K |
| 4 | Sphera Funds Management Ltd. | 678.9K | $417.3K |
| 5 | Blackrock, Inc. | 286.1K | $175.9K |
| 6 | Geode Capital Management, LLC | 277.3K | $170.4K |
| 7 | Millennium Management LLC | 258.2K | $158.7K |
| 8 | Platinum Investment Management Ltd | 233.1K | $143.3K |
| 9 | State Street Corp | 75.3K | $46.3K |
| 10 | Ubs Group AG | 45.8K | $28.1K |